Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.
Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.
Blood. 2020.
PMID: 31805182
Free PMC article.
Clinical Trial.
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial.
Halton J, Brandão LR, Luciani M, Bomgaars L, Chalmers E, Mitchell LG, Nurmeev I, Sharathkumar A, Svirin P, Gorbatikov K, Tartakovsky I, Simetzberger M, Huang F, Sun Z, Kreuzer J, Gropper S, Reilly P, Brueckmann M, Albisetti M; DIVERSITY Trial Investigators.
Halton J, et al. Among authors: simetzberger m.
Lancet Haematol. 2021 Jan;8(1):e22-e33. doi: 10.1016/S2352-3026(20)30368-9. Epub 2020 Dec 5.
Lancet Haematol. 2021.
PMID: 33290737
Clinical Trial.
Item in Clipboard
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia.
Brandão LR, Tartakovsky I, Albisetti M, Halton J, Bomgaars L, Chalmers E, Luciani M, Saracco P, Felgenhauer J, Lvova O, Simetzberger M, Sun Z, Mitchell LG.
Brandão LR, et al. Among authors: simetzberger m.
Blood Adv. 2022 Nov 22;6(22):5908-5923. doi: 10.1182/bloodadvances.2021005681.
Blood Adv. 2022.
PMID: 36150047
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite